A lot of fluff in the report but the fact is they continue to slide downwards (10% loss for the year) in an increasingly competitive and saturated market with very little room for a growth spurt for them. You would expect their expenses to go down after the previous year/s of excess. It's not so much a grand restructuring of strategic brilliance but a normalisation of expenses to match the size an opportunity of the company. They even trimmed costs by having the manager's kids do the cleaning for some pocket money. Loan interest is due in April which will add to expenses and Health Engine has a relaunch and money.
JHL Price at posting:
2.7¢ Sentiment: None Disclosure: Not Held
